Roche outlines plans to move towards autonomous AI labs
Summary
Roche, a major pharmaceutical company, is outlining its strategic plans to develop and implement autonomous AI laboratories for research and development.
Similar Articles
Anthropic wants to develop its own drugs
Anthropic announced Claude Science, an AI workbench for scientists, and revealed its own plans to develop drugs for neglected diseases using AI, entering a competitive field of AI-driven drug discovery.
Anthropic quietly sets up biology lab as it ramps AI drug program
Anthropic has quietly established a biology lab to advance its AI-driven drug discovery program.
Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare (3 minute read)
Anthropic is launching an internal AI drug discovery program to develop treatments for neglected diseases, aiming to improve its AI tools for drugmakers and join tech giants in the healthcare market.
AutoResearch AI: Towards AI-Powered Research Automation for Scientific Discovery
This survey examines the emerging field of AI-powered research automation (AutoResearch), analyzing how AI systems are moving from isolated task assistance to full workflow-level scientific discovery. It defines a spectrum from human-steered 'Vibe Research' to AI-led systems, and proposes five evaluation dimensions for scientific credibility.
@itsolelehmann: if you've been paying attention, you know there's been a serious vibe shift in AI this month 3 major AI labs (anthropic…
Three major AI labs — Anthropic, OpenAI, and Amazon — have made significant moves into biology this month, signaling a major industry shift toward AI-driven life sciences as the next frontier of value creation.